Lung Cancer

ARUP’s full service test menu includes EGFR amplification and mutation testing, EML4/ALK chromosomal rearrangement analysis by PCR, as well as KRAS, BRAF and PIK3CA mutation tests. Serum biomarkers of lung cancer include NSE, SCC and CYFRA 21-1.  ARUP also offer the MESOMARK® test, a mesothelioma blood test that measures soluble mesothelin-related proteins (SMRPs) and is useful for the management of mesothelioma patients.
  • Co-Division Chief, Anatomic and Molecular Oncologic Pathology
    Medical Director, Biocomputing
    Dr. Bronner is a Carl R. Kjeldsberg presidential endowed professor of pathology at the University of Utah School of Medicine. Dr. Bronner received her MD from the University of Pennsylvania and completed her pathology residency training and chief residency at the Hospital of the University of Pennsylvania in Philadelphia. Dr. Bronner’s honors include her election as president of the GI Pathology Society, election as council member of the United States and Canadian Academy of Pathology, and, in 2005, the award of the Arthur Purdy Stout Prize, recognizing her work as a surgical pathologist under the age of 45 whose research publications have had a major impact on diagnostic pathology. Dr. Bronner is an editorial journal board member for Human Pathology and Modern Pathology. She has served as an investigator on numerous NIH and foundation grants over the course of her career and has published more than 100 peer-reviewed articles and numerous book chapters.
  • Medical Director, Special Chemistry
    Co-Medical Director, Electrophoresis/Manual Endocrinology
    Section Chief, Chemistry
    Dr. Grenache a professor of pathology at the University of Utah School of Medicine. He earned his PhD in biomedical sciences from Worcester Polytechnic Institute in Worcester, MA and completed his postdoctoral training in clinical chemistry at Washington University School of Medicine in St. Louis, MO. Dr. Grenache is a fellow in the National Academy of Clinical Biochemistry and is board certified in clinical chemistry by the American Board of Clinical Chemistry. His research interests include reproductive biochemistry and emerging biomarkers of disease. He maintains a blog called The Pregnancy Lab, which is focused on the laboratory tests used to manage the pregnant patient.
  • Medical Director, Solid Tumor Molecular Diagnostics and Histology
    Staff Pathologist, Anatomic Pathology
    Dr. Samowitz is a professor of pathology at the University of Utah School of Medicine. He received his MD from SUNY Downstate, and completed residency training in anatomic pathology at the University of Chicago and fellowships in gastrointestinal pathology at Johns Hopkins Hospital. Specializing in gastrointestinal pathology and the molecular genetics of colorectal cancer, Dr. Samowitz is also the medical director for numerous molecular tests in solid tumor molecular diagnostics, including single-gene assays and next-generation sequencing panels.